These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 30299265)

  • 41. New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome.
    Saleem F; Rizvi SW
    Cureus; 2017 Nov; 9(11):e1844. PubMed ID: 29344438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials.
    Unfer V; Nestler JE; Kamenov ZA; Prapas N; Facchinetti F
    Int J Endocrinol; 2016; 2016():1849162. PubMed ID: 27843451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
    Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
    Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D, PCOS and androgens in men: a systematic review.
    Trummer C; Pilz S; Schwetz V; Obermayer-Pietsch B; Lerchbaum E
    Endocr Connect; 2018 Mar; 7(3):R95-R113. PubMed ID: 29449314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews.
    Gilbert EW; Tay CT; Hiam DS; Teede HJ; Moran LJ
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):683-699. PubMed ID: 30099747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polycystic ovarian syndrome: clinical and biological diagnosis.
    Bachelot A
    Ann Biol Clin (Paris); 2016 Dec; 74(6):661-667. PubMed ID: 27848917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
    Teede HJ; Meyer C; Norman RJ
    Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in the treatment of polycystic ovary syndrome.
    Yildiz BO
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1295-305. PubMed ID: 15461558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lifestyle changes in women with polycystic ovary syndrome.
    Moran LJ; Hutchison SK; Norman RJ; Teede HJ
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007506. PubMed ID: 21735412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review.
    Reis GV; Gontijo NA; Rodrigues KF; Alves MT; Ferreira CN; Gomes KB
    J Obstet Gynaecol Res; 2017 Mar; 43(3):436-446. PubMed ID: 28127831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review.
    Zhao X; Jiang Y; Xi H; Chen L; Feng X
    Geburtshilfe Frauenheilkd; 2020 Feb; 80(2):161-171. PubMed ID: 32109968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M
    Horm Metab Res; 2018 Mar; 50(3):193-200. PubMed ID: 29523006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on the management of polycystic ovary syndrome.
    Krysiak R; Okopień B; Gdula-Dymek A; Herman ZS
    Pharmacol Rep; 2006; 58(5):614-25. PubMed ID: 17085853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
    Lanzo E; Monge M; Trent M
    Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
    Patel S
    J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.